核素心肌显像在冠心病处理决策中的合理应用及其原理

李殿富

李殿富

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 2: (56-59)

引用本文:

Citation:

核素心肌显像在冠心病处理决策中的合理应用及其原理

李殿富

210029 南京, 南京医科大学第一附属医院心脏科
中图分类号: R817.4

The appropreciate use and the principles of myocardial perfusion imaging in the management of coronary artery disease

LI Dian-fu

Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
CLC number: R817.4

摘要: 核素心肌显像在冠心病诊断、危险度分层及预后判断方面积累了大量资料,并可据此制定冠心病的有效处理策略。在ACC/AHA(美国心脏病学会/美国心脏协会)有关冠心病和核心脏病学指南中,核素心肌显像的上述作用得到了充分肯定。合理应用该技术可以提高我们对冠心病诊断处理的整体水平,并使有限的医疗资源得到更合理利用,目前这在我国显得十分迫切和必要。
- 冠心病 /
- 核素心肌显像 /
- 预后 /
- 危险度分层
Abstract: Mounts of materials of myocardial perfusion imaging (MPI)have been accumulated in the diagnosis, risk stratification and prognosis of coronary artery disease (CAD), and MPI takes a key role in the management of coronary artery disease. The guidelines of American College of Cardiology and American Heart Association related to CAD have stressed the value of MPI. The appreciate utiliza-tion of MPI could improve our diagnosis and management of CAD, and this is crucial and critical in China at present.
- coronary artery disease /
- myocardial perfusion disease /
- prognosis /
- risk stratification
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Berman DS, Hayes SW, Haw LJ, et al. Recent advances in myocardial perfusion imaging[J]. Curr Pro Cordial, 2001,26:8-12.
[2]	Wackers TH, Zaret BL. Nuclear Cardiology[A]. Braunwald E, eds. Heart Diease[M]. Ed6. Philadelphia:Saunders,2001. 273-297.
[3]	Baird MG, Lorell BH, Bateman TM, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging[J]. Circulation, 2003, 108(11):1404-1418.
[4]	Law M, Wald N, Thompson S. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease[J]. BMJ, 1994, 308(6925):367-373.
[5]	Grundy SM, Pasternak R, Creenland P, et al. Assessment of cardiovascular risk by use of multiple risk factor assessment equations:a statement for healthcare professionals from the American Heart Association and the American College of Cardiology[J]. Circulation, 1999,100(13):1481-1492.
[6]	Raymond J, Jonathan A, Kanu C, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina[J]. Circulation, 2003, 108(11):149-158.
[7]	Allman EL, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease an left ventricular dysfunction:a meta-analysis[J]. J Am Coll Cardiol, 2002,39:1151-1158.
[8]	Diamond GA, Staniloff HM, Forrester JS, et al. Computerassisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease[J]. J Am Coll Cardiol, 1983, 1:444-455.
[9]	Berman DS, Kang X, Schisterman EE, et al. Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy[J]. J Nucl Cardiol, 2001, 8(4):428-437.
[10]	Yao SS, Rozanski A. Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease[J]. Prog Cardiovasc Dis,2001, 43(4):281-302.
[11]	Antman EM, Braunwald E. Acute myocardial infarction[A].Braunwald E. Heart Diease[M]. 6th ed. Philadelphea:Saunders, 2001.1185-1287.
[12]	Traverse JH, Wang LY, Du RS, et al. Coronary nitric oxide production in response to exercise and endothelium-dependent agonists[J]. Circulation, 2000, 30:2526-2531.
[13]	Libby P. Current concepts of the pathogenesis of the acute coronary syndromes[J]. Circulation, 2001, 104:365-372.

[1]	李殿富 . 慢性稳定型冠心病的核素心肌灌注显像临床应用进展. 国际放射医学核医学杂志, 2004, 28(3): 97-100.
[2]	李胜亭 , 刘秀杰 . 心肌显像估测冠心病预后的价值. 国际放射医学核医学杂志, 1996, 20(1): 4-8.
[3]	陈小明 . SPECT在冠心病危险度分层方面的应用. 国际放射医学核医学杂志, 2004, 28(3): 101-105.
[4]	王勤奋 . 心肌活力测定的研究进展. 国际放射医学核医学杂志, 2005, 29(4): 155-158.
[5]	郭小闪 , 靳春荣 , 武志芳 , 武萍 , 李莉 , 陈伟强 , 李思进 . 瑞加诺生负荷心肌灌注显像诊断冠心病的初步临床研究. 国际放射医学核医学杂志, 2020, 44(10): 634-640. doi: 10.3760/cma.j.cn121381-202003048-00088
[6]	张建萍 , 刘雪辉 , 于泓煦 , 刘娜 , 沈慧 , 陈兵 . 心肌灌注显像引导下行PCI治疗的Graves甲亢合并冠心病一例. 国际放射医学核医学杂志, 2019, 43(6): 589-592. doi: 10.3760/cma.j.issn.1673-4114.2019.06.016
[7]	孙璐冰 , 阮翘 . 心肌灌注显像联合冠状动脉钙化积分诊断冠心病的价值及最新进展. 国际放射医学核医学杂志, 2017, 41(2): 143-149. doi: 10.3760/cma.j.issn.1673-4114.2017.02.012
[8]	栾兆生 , 田嘉禾 . 单光子核素显像在冠心病介入治疗中的应用. 国际放射医学核医学杂志, 1997, 21(3): 97-100.
[9]	彭琨 , 陈卫强 , 李剑明 . 冠状动脉血流储备分数、心肌血流储备和微循环阻力指数在冠心病患者中的临床应用价值. 国际放射医学核医学杂志, 2019, 43(5): 462-467. doi: 10.3760/cma.j.issn.1673-4114.2019.05.014
[10]	张科 , 谭红霞 , 宋波 . ⁹⁹Tc^m-MIBI心肌灌注显像对行PCI术的冠心病患者中的近期效果的评估作用. 国际放射医学核医学杂志, 2019, 43(5): 422-426. doi: 10.3760/cma.j.issn.1673-4114.2019.05.007

点击查看大图

计量

文章访问数: 1239
HTML全文浏览量: 141
PDF下载量: 2

核素心肌显像在冠心病处理决策中的合理应用及其原理

李殿富

210029 南京, 南京医科大学第一附属医院心脏科

收稿日期: 2004-10-16

关键词:

摘要: 核素心肌显像在冠心病诊断、危险度分层及预后判断方面积累了大量资料,并可据此制定冠心病的有效处理策略。在ACC/AHA(美国心脏病学会/美国心脏协会)有关冠心病和核心脏病学指南中,核素心肌显像的上述作用得到了充分肯定。合理应用该技术可以提高我们对冠心病诊断处理的整体水平,并使有限的医疗资源得到更合理利用,目前这在我国显得十分迫切和必要。